Harvia Oyj
HARVIA PLC STOCK EXCHANGE RELEASE 12 FEBRUARY 2021 AT 11.45 A.M. EET
Harvia Oyj - Managers' Transactions
____________________________________________
Person subject to the notification requirement
Name: Kekkonen Kalle
Position: Member of the Board/Deputy member
Issuer: Harvia Oyj
LEI: 7437002ULTBOWQQOXL69
Notification type: INITIAL NOTIFICATION
Reference number: 7437002ULTBOWQQOXL69_20210212110334_4
____________________________________________
Transaction date: 2021-02-12
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000306873
Nature of the transaction: ACQUISITION
Transaction details
(1): Volume: 1,500 Unit price: 31.5 EUR
Aggregated transactions
(1): Volume: 1,500 Volume weighted average price: 31.5 EUR
Additional information:
Ari Vesterinen, CFO
tel. +358 40 5050 440
ari.vesterinen@harvia.fi
Harvia is one of the leading companies operating in the sauna and spa market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna and spa market of both private and professional customers.
Harvia’s revenue totaled EUR 109.1 million in 2020. Harvia Group employs more than 600 professionals in Finland, China and Hong Kong, Romania, Austria, United States, Germany, Estonia and Russia. The company is headquartered in Muurame, Finland, adjacent to its largest sauna and sauna component manufacturing facility.
Read more: https://harviagroup.com
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Reinventy Solutions Corp31.12.2025 15:30:00 CET | Press release
Reinventy Introduces Shield Brain (Codename “The Tin Man”)
Novo Nordisk A/S31.12.2025 14:24:27 CET | Press release
Novo Nordisk A/S: China’s Supreme People’s Court delivers a positive ruling on the semaglutide compound patent
Lassila & Tikanoja plc31.12.2025 13:30:00 CET | Press release
Change of issuer of Lassila & Tikanoja’s EUR 75 million sustainability-linked notes
Lassila & Tikanoja plc31.12.2025 13:10:00 CET | Press release
The partial demerger of Lassila & Tikanoja plc has been registered – New Lassila & Tikanoja to be listed on Nasdaq Helsinki
Lassila & Tikanoja plc31.12.2025 13:00:00 CET | Press release
The partial demerger of Lassila & Tikanoja plc has been registered – New Lassila & Tikanoja to be listed on Nasdaq Helsinki
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
